Please login or register first to view this content.
Dermatological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Deucravacitinib Under Review for Moderate to Severe Plaque Psoriasis
Atopic Dermatitis Linked to Shorter Stature in Early Childhood
Review Profiles Open-Access Datasets With Skin Cancer Images
Oral Nadolol Feasible for the Treatment of Infantile Hemangiomas
FDA Grants Fast Track Designation to Orismilast for Atopic Dermatitis
Acne Vulgaris Treatment Winlevi Now Available
FDA Adds Restrictions, Updates Labeling for Breast Implants
Seven Best Diagnostic Criteria ID’d for Childhood Psoriasis
Dupilumab Reduced Itch, Skin Lesions in Patients With Prurigo Nodularis
Psoriatic Arthritis May Up Risk for Preterm Birth, C-Section
First Interchangeable Biosimilar to Humira Gets FDA Approval
Travel Restrictions Hinder Bimekizumab BLA Review
Cudetaxestat Gets Orphan Drug Status for Systemic Sclerosis
FDA Announces Modifications to iPLEDGE REMS Program
FDA: Needle-Free Devices Should Not Be Used to Inject Dermal Fillers
Infection Risk Does Not Seem to Differ Among Biologics for Psoriasis
COVID-19 Vaccine Concerns ID’d in Psoriasis, Psoriatic Arthritis Patients
Use of Antihypertensive Drugs May Increase Risk for Psoriasis
